Literature DB >> 35614098

Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata.

Pablo Catalán1,2, Emily Wood3, Jessica M A Blair4, Ivana Gudelj3, Jonathan R Iredell5,6,7, Robert E Beardmore8.   

Abstract

Antibiotic resistance represents a growing medical concern where raw, clinical datasets are under-exploited as a means to track the scale of the problem. We therefore sought patterns of antibiotic resistance in the Antimicrobial Testing Leadership and Surveillance (ATLAS) database. ATLAS holds 6.5M minimal inhibitory concentrations (MICs) for 3,919 pathogen-antibiotic pairs isolated from 633k patients in 70 countries between 2004 and 2017. We show most pairs form coherent, although not stationary, timeseries whose frequencies of resistance are higher than other databases, although we identified no systematic bias towards including more resistant strains in ATLAS. We sought data anomalies whereby MICs could shift for methodological and not clinical or microbiological reasons and found artefacts in over 100 pathogen-antibiotic pairs. Using an information-optimal clustering methodology to classify pathogens into low and high antibiotic susceptibilities, we used ATLAS to predict changes in resistance. Dynamics of the latter exhibit complex patterns with MIC increases, and some decreases, whereby subpopulations' MICs can diverge. We also identify pathogens at risk of developing clinical resistance in the near future.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35614098      PMCID: PMC9133080          DOI: 10.1038/s41467-022-30635-7

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  56 in total

1.  Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing.

Authors:  Michael Hombach; Carlos Ochoa; Florian P Maurer; Tamara Pfiffner; Erik C Böttger; Reinhard Furrer
Journal:  J Antimicrob Chemother       Date:  2015-10-12       Impact factor: 5.790

2.  Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values.

Authors:  J Turnidge; G Kahlmeter; G Kronvall
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

Review 3.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

4.  AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.

Authors:  Jessica M A Blair; Vassiliy N Bavro; Vito Ricci; Niraj Modi; Pierpaolo Cacciotto; Ulrich Kleinekathӧfer; Paolo Ruggerone; Attilio V Vargiu; Alison J Baylay; Helen E Smith; Yvonne Brandon; David Galloway; Laura J V Piddock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

5.  Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.

Authors:  Sanjay Merchant; Chris Gast; Dilip Nathwani; Michael Lee; Alvaro Quintana; Nzeera Ketter; Ian Friedland; Michael Ingham
Journal:  Clin Ther       Date:  2008-04       Impact factor: 3.393

6.  Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE).

Authors:  Sandra Fournier; Christian Brun-Buisson; Vincent Jarlier
Journal:  Antimicrob Resist Infect Control       Date:  2012-02-13       Impact factor: 4.887

7.  Assessment of Doripenem, Meropenem, and Imipenem against Respiratory Isolates of Pseudomonas aeroginosa in a Tertiary Care Hospital of North India.

Authors:  Arti Negi; Mridu Anand; Avinash Singh; Awadhesh Kumar; Chinmoy Sahu; Kashi Nath Prasad
Journal:  Indian J Crit Care Med       Date:  2017-10

8.  Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.

Authors:  Vincent Trebosc; Sarah Gartenmann; Marcus Tötzl; Valentina Lucchini; Birgit Schellhorn; Michel Pieren; Sergio Lociuro; Marc Gitzinger; Marcel Tigges; Dirk Bumann; Christian Kemmer
Journal:  mBio       Date:  2019-07-16       Impact factor: 7.867

9.  Temporal variation in antibiotic environments slows down resistance evolution in pathogenic Pseudomonas aeruginosa.

Authors:  Roderich Roemhild; Camilo Barbosa; Robert E Beardmore; Gunther Jansen; Hinrich Schulenburg
Journal:  Evol Appl       Date:  2015-10-07       Impact factor: 5.183

10.  Molecular Epidemiology and Antimicrobial Resistance of Haemophilus influenzae in Adult Patients in Shanghai, China.

Authors:  Xin-Xin Li; Shu-Zhen Xiao; Fei-Fei Gu; Wei-Ping He; Yu-Xing Ni; Li-Zhong Han
Journal:  Front Public Health       Date:  2020-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.